[Federal Register Volume 80, Number 228 (Friday, November 27, 2015)]
[Proposed Rules]
[Pages 74056-74058]
[FR Doc No: 2015-30022]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2015-5813; Directorate Identifier 2014-NM-111-AD]
RIN 2120-AA64

Airworthiness Directives; Dassault Aviation Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: We propose to adopt a new airworthiness directive (AD) for
certain Dassault Aviation Model FALCON 7X airplanes. This proposed AD
was prompted by a fuel leak that occurred in the baggage compartment
during fuel system pressurization. This proposed AD would require
opening the fuel boxes and restoring the sealing. We are proposing this
AD to detect and correct failure of a connector or coupling on a fuel
line, which, in combination with a leak in the corresponding enclosure
(i.e., fuel box), could result in a fire in the baggage compartment and
affect the safe flight of the airplane.

DATES: We must receive comments on this proposed AD by January 11,
2016.

ADDRESSES: You may send comments, using the procedures found in 14 CFR
11.43 and 11.45, by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    For service information identified in this proposed AD, contact
Dassault Falcon Jet, P.O. Box 2000, South Hackensack, NJ 07606;
telephone<PHONE_NUMBER>; Internet http://www.dassaultfalcon.com. You may
view this referenced service information at the FAA, Transport Airplane
Directorate, 1601 Lind Avenue SW., Renton, WA. For information on the
availability of this material at the FAA, call<PHONE_NUMBER>.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov by searching for and locating Docket No. FAA-2015-
5813; or in person at the Docket Management Facility between 9 a.m. and
5 p.m., Monday through Friday, except Federal holidays. The AD docket
contains this proposed AD, the regulatory evaluation, any comments
received, and other information. The street address for the Docket
Operations office (telephone<PHONE_NUMBER>) is in the ADDRESSES section.
Comments will be available in the AD docket shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Tom Rodriguez, Aerospace Engineer,
International Branch, ANM-116, Transport Airplane Directorate, FAA,
1601 Lind Avenue SW., Renton, WA 98057-3356; telephone<PHONE_NUMBER>;
fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposed AD. Send your comments to an address
listed under the ADDRESSES section. Include ``Docket No. FAA-2015-5813;
Directorate Identifier 2014-NM-111-AD'' at the beginning of your
comments. We specifically invite comments on the overall regulatory,
economic, environmental, and energy aspects of this proposed AD. We
will consider all comments received by the closing date and may amend
this proposed AD based on those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    The European Aviation Safety Agency (EASA), which is the Technical
Agent for the Member States of the European Union, has issued EASA
Airworthiness Directive 2014-0116, dated May 13, 2014 (referred to
after this as the Mandatory Continuing Airworthiness Information, or
``the MCAI''), to correct an unsafe condition for certain Dassault
Aviation Model FALCON 7X airplanes. The MCAI states:

    During the fuel system pressurization of a production line
Falcon 7X aeroplane, a fuel leak occurred in the baggage
compartment. The technical investigations concluded that a double
failure of a connector (or coupling) on a fuel line, in combination
with a defective fuel tightness of the corresponding enclosure (fuel
box), caused the leak.
    Failure of the second barrier (fuel box) is a dormant failure,
as this will only manifest itself in case of connector (or fuel pipe
coupling) failure in flight.
    This condition, if not corrected, could result in a fire in the
baggage compartment, which would affect the aeroplane safe flight.
    To address this potential unsafe condition, Dassault Aviation
issued Service Bulletin (SB) F7X-284, which provides instructions to
restore the sealing of the Left Hand (LH) and Right Hand (RH) fuel
boxes.
    For the reasons described above, this [EASA] AD requires opening
of the fuel boxes and restoration of the sealing of the fuel boxes
to meet the initial design specifications.

    You may examine the MCAI in the AD docket on the Internet at http://www.regulations.gov by searching for and locating Docket No. FAA-2015-
5813.

Related Service Information Under 1 CFR Part 51

    Dassault Aviation has issued Service Bulletin 7X-284, Revision 1,
dated

April 8, 2014. The service information describes procedures for opening
the fuel boxes and restoring the sealing. This service information is
reasonably available because the interested parties have access to it
through their normal course of business or by the means identified in
the ADDRESSES section of this NPRM.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to our bilateral agreement with the State of Design Authority, we have
been notified of the unsafe condition described in the MCAI and service
information referenced above. We are proposing this AD because we
evaluated all pertinent information and determined an unsafe condition
exists and is likely to exist or develop on other products of the same
type design.

Costs of Compliance

    We estimate that this proposed AD affects 39 airplanes of U.S.
registry.
    We also estimate that it would take about 16 work-hours per product
to comply with the basic requirements of this proposed AD. The average
labor rate is $85 per work-hour. Required parts are negligible. Based
on these figures, we estimate the cost of this proposed AD on U.S.
operators to be $53,040, or $1,360 per product.
    According to the manufacturer, all of the costs of this proposed AD
may be covered under warranty, thereby reducing the cost impact on
affected individuals. We do not control warranty coverage for affected
individuals. As a result, we have included all costs in our cost
estimate.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979);
    3. Will not affect intrastate aviation in Alaska; and
    4. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive (AD):

Dassault Aviation: Docket No. FAA-2015-5813; Directorate Identifier
2014-NM-111-AD.

(a) Comments Due Date

    We must receive comments by January 11, 2016.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Dassault Aviation Model FALCON 7X airplanes,
certificated in any category, serial numbers (S/Ns) 1 through 140
inclusive, S/Ns 142 through 156 inclusive, S/Ns 158 through 176
inclusive, S/Ns 178 through 181 inclusive, and S/N 183, 184, 187,
188, 190, 194, and 200.

(d) Subject

    Air Transport Association (ATA) of America Code 28, Fuel.

(e) Reason

    This AD was prompted by a fuel leak that occurred in the baggage
compartment during fuel system pressurization. We are issuing this
AD to prevent failure of a connector or coupling on a fuel line,
which, in combination with a leak in the corresponding enclosure
(i.e., fuel box), could result in a fire in the baggage compartment
and affect the safe flight of the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Open the Fuel Box and Restore the Sealing

    Within 98 months after the effective date of this AD, open the
left-hand and right-hand fuel boxes and restore the sealing, in
accordance with the Accomplishment Instructions of Dassault Service
Bulletin 7X-284, Revision 1, dated April 8, 2014.

(h) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
International Branch, ANM-116, Transport Airplane Directorate, FAA,
has the authority to approve AMOCs for this AD, if requested using
the procedures found in 14 CFR 39.19. In accordance with 14 CFR
39.19, send your request to your principal inspector or local Flight
Standards District Office, as appropriate. If sending information
directly to the International Branch, send it to ATTN: Tom
Rodriguez, Aerospace Engineer, International Branch, ANM-116,
Transport Airplane Directorate, FAA, 1601 Lind Avenue SW., Renton,
WA 98057-3356; telephone<PHONE_NUMBER>; fax<PHONE_NUMBER>.
Information may be emailed to<EMAIL_ADDRESS>
Before using any approved AMOC, notify your appropriate principal
inspector, or lacking a principal inspector, the manager of the
local flight standards district office/certificate holding district
office. The AMOC approval letter must specifically reference this
AD.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain corrective actions from a manufacturer, the action must be
accomplished using a method approved by the Manager, International
Branch, ANM-116, Transport Airplane Directorate, FAA; or the
European Aviation Safety Agency (EASA); or Dassault Aviation's EASA
Design Organization Approval (DOA). If approved by the DOA, the
approval must include the DOA-authorized signature.

(i) Related Information

    (1) Refer to Mandatory Continuing Airworthiness Information
(MCAI) EASA Airworthiness Directive 2014-0116, dated May 13, 1014,
for related information. This MCAI may be found in the AD docket on
the Internet at http://www.regulations.gov by

searching for and locating Docket No. FAA-2015-5813.
    (2) For service information identified in this AD, contact
Dassault Falcon Jet, P.O. Box 2000, South Hackensack, NJ 07606;
telephone<PHONE_NUMBER>; Internet http://www.dassaultfalcon.com. You
may view this service information at the FAA, Transport Airplane
Directorate, 1601 Lind Avenue SW., Renton, WA. For information on
the availability of this material at the FAA, call<PHONE_NUMBER>.

    Issued in Renton, Washington, on November 17, 2015.
Jeffrey E. Duven,
Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. 2015-30022 Filed 11-25-15; 8:45 am]
 BILLING CODE 4910-13-P


[Federal Register Volume 85, Number 4 (Tuesday, January 7, 2020)]
[Notices]
[Pages 716-718]
[FR Doc No: 2020-00034]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-5971]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Recommendations To Reduce the Risk of Transfusion-
Transmitted of Infection in Whole Blood and Blood Components; Agency
Guidance

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
an opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments concerning establishment
notification of a consignee and consignee notification of a recipient's
physician of record regarding a possible increased risk of transfusion-
transmitted infection.

DATES: Submit either electronic or written comments on the collection
of information by March 9, 2020.

ADDRESSES: You may submit comments as follows. Please note that late
untimely filed comments will not be considered. Electronic comments
must be submitted on or before March 9, 2020. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of March 9, 2020. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically,

including attachments, to https://www.regulations.gov will be posted to
the docket unchanged. Because your comment will be made public, you are
solely responsible for ensuring that your comment does not include any
confidential information that you or a third party may not wish to be
posted, such as medical information, your or anyone else's Social
Security number, or confidential business information, such as a
manufacturing process. Please note that if you include your name,
contact information, or other information that identifies you in the
body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2019-N-5971 for ``Use of Serological Tests to Reduce the Risk of
the Transfusion-Transmitted Infection in Whole Blood and Blood
Components; Agency Guidance.'' Received comments, those filed in a
timely manner (see ADDRESSES) will be placed in the docket and, except
for those submitted as ``Confidential Submissions,'' publicly viewable
at https://www.regulations.gov or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Recommendations To Reduce the Risk of Transfusion-Transmitted Infection
in Whole Blood and Blood Components; Agency Guidance

OMB Control Number 0910-0681--Extension

    Under Sec.  630.3(h) (21 CFR 630.3(h)), a list is set forth of
relevant transfusion-transmitted infections (RTTIs) (Sec.  630.3(h)(1))
and the conditions under which a transfusion-transmitted infection
(TTI) would meet the definition of an RTTI (Sec.  630.3(h)(2)). The
list of RTTIs under Sec.  630.3(h)(1) includes, among other things, the
following: Trypanosoma cruzi (Chagas), Creutzfeldt Jacob Disease (CJD)/
variant Creutzfeldt Jacob Disease (vCJD), plasmodium species (malaria),
and West Nile virus. The RTTIs FDA has identified thus far under Sec.
630.3(h)(2) include Zika virus and babesiosis. In addition, FDA has
determined Ebola virus to be a TTI identified under Sec.  630.3(l). FDA
has issued several guidance documents with recommendations regarding
the RTTIs or TTIs including Chagas, babesiosis, Zika virus, West Nile
virus Ebola virus, malaria, CJD and vCJD, human immunodeficiency virus
(HIV) and human T-lymphotropic virus, types I and II (HTLV).
    The Chagas, babesiosis, Zika virus and West Nile virus, and HTLV
guidance documents provide recommendations for consignee and physician
notification relating to donors that tested reactive for these
infections.
    In addition, a blood establishment may receive information from a
donor following collection that reveals the donor had a risk factor for
a RTTI or TTI at the time of collection and should have been deferred
for the risk factor. FDA has recommended, in the following guidance
documents, that such a blood collection establishment notify the
consignee regarding the distributed blood components that are
potentially at-risk for a RTTI or TTI. In some cases,

we recommend that if the blood was transfused, the consignee notify the
transfusion recipient's physician of record regarding the potential
risk. This recommendation is included in Ebola virus, malaria, CJD and
vCJD, and HIV guidance documents. These guidance documents are
available from our website at https://www.fda.gov/vaccines-blood-biologics/biologics-guidances/blood-guidances.
    Although such notifications are rare, we believe that these
notification practices would be part of the usual and customary
business practice for blood establishments and consignees in addressing
the RTTIs or TTIs under the regulations. In addition, we believe
respondents would have already developed standard operating procedures
for notifying consignees and the recipient's physician of record
regarding distributed blood components potentially at risk for a TTI.
Therefore, for the purpose of estimating burden under the PRA, we
provide an estimate of one response and one burden hour annually.
    As other relevant transfusion-transmitted infections are determined
under Sec.  630.3, we may continue to issue guidance accordingly, and,
if approved, intend the information collections to be included under
this OMB control number.
    Based on a review of the information collection since our last
request for OMB approval, we have made no adjustments to our burden
estimates. These guidance documents, as applicable, also refer to
previously approved collections of information found in FDA
regulations. The collections of information in 21 CFR parts 601 and
640, and Form FDA 356h have been approved under OMB control number
0910-0338; the collections of information in 21 CFR parts 606 and 630
have been approved under OMB control number 0910-0116; the collections
of information in 21 CFR 606.171 have been approved under OMB control
number 0910-0458.

    Dated: December 31, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-00034 Filed 1-6-20; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)]
[Notices]
[Page 32698]
[FR Doc No: 2017-14875]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC17-128-000.
    Applicants: Beech Ridge Energy LLC, Beech Ridge Energy II LLC,
Beech Ridge Energy Storage LLC, Bishop Hill Energy III LLC, Bishop Hill
Interconnection LLC, Buckeye Wind Energy LLC, Forward Energy LLC, Grand
Ridge Energy LLC, Grand Ridge Energy II LLC, Grand Ridge Energy III
LLC, Grand Ridge Energy IV LLC, Grand Ridge Energy V LLC, Grand Ridge
Energy Storage LLC, Gratiot County Wind LLC, Gratiot County Wind II
LLC, Invenergy TN LLC, Judith Gap Energy LLC, Prairie Breeze Wind
Energy II LLC, Prairie Breeze Wind Energy III LLC, Sheldon Energy LLC,
Spring Canyon Energy LLC, Stony Creek Energy LLC, Vantage Wind Energy
LLC, Willow Creek Energy LLC, Wolverine Creek Energy LLC, Wolverine
Creek Goshen Interconnection LLC.
    Description: Supplement to June 8, 2017 Application for
Authorization Under Section 203 of the Federal Power Act, et al. of
Beech Ridge Energy LLC, et al.
    Filed Date: 7/6/17.
    Accession Number: 20170706-5172.
    Comments Due: 5 p.m. ET 7/17/17.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-2964-014.
    Applicants: Selkirk Cogen Partners, L.P.
    Description: Triennial Market Power Update of Selkirk Cogen
Partners, L.P.
    Filed Date: 6/30/17.
    Accession Number: 20170630-5472.
    Comments Due: 5 p.m. ET 8/29/17.

    Docket Numbers: ER11-4573-001.
    Applicants: Evergreen Community Power, LLC.
    Description: Notice of Non-Material Change In Status for Evergreen
Community Power, LLC.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5316.
    Comments Due: 5 p.m. ET 7/31/17.

    Docket Numbers: ER17-1192-002.
    Applicants: Otter Tail Power Company.
    Description: Tariff Amendment: Amendment to Submit Restated
Conforming Agreement--Rate Schedule No. 168 to be effective 7/30/2010.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5251.
    Comments Due: 5 p.m. ET 7/31/17.

    Docket Numbers: ER17-2066-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Pseudo-Tie Cost
Reimbursement Agreements SA. Nos. 4751 and 4752 to be effective 7/8/
2017.
    Filed Date: 7/7/17.
    Accession Number: 20170707-5162.
    Comments Due: 5 p.m. ET 7/28/17.

    Docket Numbers: ER17-2067-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: 2017-07-10 Ameren-Prairie
Power Wholesale Connection and Umbrella Construction to be effective 6/
8/2017.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5252.
    Comments Due: 5 p.m. ET 7/31/17.

    Docket Numbers: ER17-2068-000.
    Applicants: California Independent System Operator Corporation.
    Description: Sec.  205(d) Rate Filing: 2017-07-10 Operating
Agreement between CAISO and MWD to be effective 10/1/2017.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5295.
    Comments Due: 5 p.m. ET 7/31/17.

    Docket Numbers: ER17-2069-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Tariff Cancellation: Notice of Cancellation of
Original Service Agreement No. 4430, Queue #AB1-099 to be effective 8/
20/2017.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5304.
    Comments Due: 5 p.m. ET 7/31/17.

    Docket Numbers: ER17-2070-000.
    Applicants: PJM Interconnection, L.L.C.
    Description: Sec.  205(d) Rate Filing: Queue Position AA2-068,
Original Service Agreement No. 4740 to be effective 6/20/2017.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5319.
    Comments Due: 5 p.m. ET 7/31/17.

    Docket Numbers: ER17-2071-000.
    Applicants: ITC Midwest LLC.
    Description: Sec.  205(d) Rate Filing: Filing of Amended and
Restated Duane Arnold Energy Center Agreement to be effective 9/8/2017.
    Filed Date: 7/10/17.
    Accession Number: 20170710-5375.
    Comments Due: 5 p.m. ET 7/31/17.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: July 10, 2017.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2017-14875 Filed 7-14-17; 8:45 am]
 BILLING CODE 6717-01-P